Best in Biotech 30 Jan 2025 Seven genome sequencing companies to look out for …with Danish pharma giant Novo Nordisk to gain a deeper understanding of the relationship between genetic variation and metabolism to yield drug targets to treat metabolic diseases such as diabetes… January 30, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Jul 2024 The 7 biotech companies in Portugal you should know about in 2024 …mediated by the immune system, including infections, inflammation, and metabolic diseases. The technology, originating at the Henrique Veiga Fernandes lab in Portugal, regulates a specific type of immune cells called… July 9, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Interview 25 Sep 2017 Meet the Founder & CEO of Galapagos, Europe’s Biotech Role Model …we’ve focused very much on inflammation, be it rheumatoid arthritis or osteoarthritis or fibrosis, but nowadays we also have programs in metabolic diseases and Hepatitis B. When we have a… September 25, 2017 - 10 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology …is successfully entrapped into a vector. The focus of its pipeline is on cancer, infectious diseases, and rare diseases. Its mRNA-based COVID-19 vaccine targeting SARS-2-COV-2 Omicron is in phase 3… October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Nov 2024 Six bispecific antibody companies you should know about …this growth are thought to be rising incidences of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, rising demand for targeted therapies, and advancements in antibody engineering technologies…. November 19, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Apr 2024 Seven diseases CRISPR technology could cure CRISPR technology offers the promise to cure human genetic diseases with gene editing. This promise became a reality when the world’s first CRISPR therapy was approved by regulators to treat… April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Feb 2023 Astex and Cardiff University Medicines Discovery Institute to collaborate on neurodegenerative diseases Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system and The Medicines Discovery… February 14, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2024 Five biosimilar companies you should know about …Stelara is used to treat. Meanwhile, Simlandi, which was approved in February 2024, is for the treatment of a long list of diseases: adult rheumatoid arthritis, juvenile idiopathic arthritis, adult… December 5, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2022 New Replay HSV gene therapy company Telaria to focus on skin diseases Replay has announced the launch of Telaria, a herpes simplex virus (HSV) gene therapy company targeting rare skin diseases. It is the second of Replay’s product companies to leverage its… November 21, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 12 Dec 2022 Artificial intelligence: a new era in rare genetic disease diagnosis …Despite this progress, diagnosing rare genetic diseases often ends in inconclusive results. Current challenges in diagnosing rare genetic diseases Paradoxically, the strength and weakness of modern genome-based sequencing technologies is… December 12, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2025 AAVantgarde closes $141 million series B round to tackle inherited eye diseases …about 4.7 kilobases of DNA, barely enough for many of the genes implicated in inherited retinal diseases. Both diseases AAVantgarde Bio chose to target have long been seen as technically… November 3, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 28 Oct 2022 Migraines: a new vaccine frontier beyond infectious diseases By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S. company Vaxxinity aims to open a new frontier for vaccines in an effort to reach… October 28, 2022 - 7 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email